Viewing Study NCT07040059


Ignite Creation Date: 2025-12-24 @ 2:39 PM
Ignite Modification Date: 2026-04-10 @ 1:08 AM
Study NCT ID: NCT07040059
Status: RECRUITING
Last Update Posted: 2025-06-26
First Post: 2025-06-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1b/2 Clinical Trial Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AUR103 Calcium in Patients With HER2-positive Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
Sponsor: Aurigene Discovery Technologies Limited
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-03-22
Start Date Type: ACTUAL
Primary Completion Date: 2027-11
Primary Completion Date Type: ESTIMATED
Completion Date: 2028-11
Completion Date Type: ESTIMATED
First Submit Date: 2025-06-04
First Submit QC Date: None
Study First Post Date: 2025-06-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-06-19
Last Update Post Date: 2025-06-26
Last Update Post Date Type: ACTUAL